Table 1.
Effects of vehicle or 17 β-estradiol (E2) pretreatment on hOB cell conversion of 1-[14C]arachidonic acid into prostaglandinsa
| Treatment | PGE2, %b | 6-keto-PGFb1α, % |
|---|---|---|
| Control | 2.8 ± 0.3 | 1.9 ± 0.2 |
| Control + E2 | 2.4 ± 0.4 | 1.5 ± 0.3 |
| TGFβ | 10.3 ± 2.3 | 2.8 ± 0.2 |
| TGFβ + E2 | 9.1 ± 1.6 | 2.6 ± 0.3 |
| TNF | 10.9 ± 2.3 | 2.7 ± 0.4 |
| TNF + E 2 | 9.6 ± 1.5 | 2.5 ± 0.4 |
| TGFβ + TNF | 27.6 ± 2.4 | 2.7 ± 0.4 |
| TGFβ + TNF + E2 | 28.6 ± 2.9 | 2.7 ± 0.4 |
hOB cells were incubated for 48 hours with vehicle (0.1% ethanol) or with 17 β-estradiol (E2 ), and then stimulated with the cytokines, as indicated, for 24 hours. The conditioned media were collected and individual prostaglandins were separated by TLC.
Data are calculated as the % cpm of individual prostaglandin bands vs. the total cpm of the scraped and scintillation-counted TLC lane. Each of the cytokine treatments stimulated product (PGE2, 6-keto-PGF1α) formation, irrespective of 17 β-E2 pretreatment (p ≤ 0.05)